Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
Sponsor: University of Aarhus
Summary
Investigating cytotoxicity of yellow fever specific CD8 T cells following YF-17D vaccination and the following licensing of these epitope-specific CD8 T cells
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2019-10-08
Completion Date
2025-12-15
Last Updated
2025-03-27
Healthy Volunteers
Yes
Interventions
Yellow Fever Vaccine
STAMARIL, powder and solvent for suspension for injection in pre-filled syringe. After reconstitution, 1 dose (0.5 ml) contains: Yellow fever virus1 17D-204 strain (live, attenuated) not less than 1000 IU. Powder and solvent for suspension for injection. Before reconstitution, the powder is homogeneous, beige to orange beige, and the solvent is a limpid solution.
Locations (1)
Aarhus University Hospital
Aarhus, Denmark